Protalix Biotherapeutics Inc Cash Flow Reinvestment Rate
Protalix Biotherapeutics Inc cash flow reinvestment rate. Protalix Biotherapeutics Inc (PLX) has a Cash Flow Reinvestment Rate of 0.61x as of December 2025, reinvesting $1.24 Million (capex $1.24 Million ) from operating cash flow of $2.03 Million. Explore Protalix Biotherapeutics Inc (PLX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Protalix Biotherapeutics Inc (2009–2024)
Cash flow reinvestment rate of Protalix Biotherapeutics Inc from 2009 to 2024. Historical reinvestment intensity for Protalix Biotherapeutics Inc across 3 annual periods. Explore Protalix Biotherapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Protalix Biotherapeutics Inc Cash Flow Reinvestment Rate by Year (2009–2024)
Protalix Biotherapeutics Inc cash flow reinvestment rate by year from 2009 to 2024. Year-by-year capital reinvestment analysis for Protalix Biotherapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Protalix Biotherapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.63x | $5.50 Million | $8.67 Million | $1.28 Million | ▼ -80.5% |
| 2012 | 3.26x | $2.07 Million | $635.00K | $2.07 Million | ▲ +2236.8% |
| 2009 | 0.14x | $6.20 Million | $44.45 Million | $6.20 Million | — |